Acanthosis Nigricans: Variant Responds to Targeted Therapy



Early identification of the EGFR L858R variant in syndromic acanthosis enables effective treatment of skin and pulmonary manifestations, according to a case series.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/acanthosis-nigricans-germline-egfr-l858r-variant-responds-2026a10004ui?src=rss

Author :

Publish date : 2026-02-16 13:27:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version